We are absolutely thrilled to share EVX Ventures’ 2021 Year in Review. Check out our latest Year in Review to learn more:
2021 YEAR IN REVIEW_EVX NEWSLETTER_A4_012822 v5 compressed
.pdf
Download PDF • 1.32MB
EVX Ventures | 2021 Year In Review
Recent Posts
See AllAdvancing the next generation of cell and gene therapies via a “platform of platforms” model SINGAPORE, Nov. 1, 2021 /PRNewswire/ -- Carcell Biopharma ("Carcell", the "Company") announced today the cl
SINGAPORE, June 18, 2021 /PRNewswire/ -- Nuevocor, a preclinical-stage biotech company specializing in gene therapy for cardiomyopathies, has announced the completion of an oversubscribed $24 million
CAMBRIDGE, Mass., May 5, 2021 /PRNewswire/ -- Carmine Therapeutics, Inc., an emerging leader in gene therapy, today announced that Don Haut, PhD has been appointed as its Chief Executive Officer, and